Vmn2r3 activators comprise a diverse chemical class that encompasses compounds capable of modulating the signaling pathways associated with the Vmn2r3 receptor. These activators are typically involved in the intricate web of intracellular processes that can lead to the activation of the Vmn2r3 receptor, which is a part of the vomeronasal system involved in pheromone detection. The compounds often target key enzymes and molecules that play a fundamental role in G protein-coupled receptor (GPCR) signaling, which is the underlying mechanism for Vmn2r3 activation. For instance, certain activators work by increasing the levels of intracellular cyclic AMP (cAMP), a pivotal second messenger in GPCR pathways, through the activation of adenylyl cyclase or inhibition of phosphodiesterase. Others can influence the pathway by altering the intracellular calcium concentration, which is another critical second messenger in GPCR signaling.
The range of chemicals within this class includes those that can modulate protein kinases, which are enzymes that phosphorylate target proteins and change their function. By modulating these kinases, Vmn2r3 activators can affect the phosphorylation status of proteins within the receptor's signaling cascade, thereby influencing the receptor's activity. Additionally, some chemicals can affect G protein activity by either activating or inhibiting these proteins, thereby modulating the receptor's signaling output. The activation or inhibition of these G proteins can lead to a variety of downstream effects, including changes in ion channel activity and alterations in the levels of other second messengers such as diacylglycerol (DAG) and inositol trisphosphate (IP3). Through these diverse mechanisms, Vmn2r3 activators can play a critical role in the regulation of the receptor's function and its ability to transduce signals within the olfactory system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, resulting in increased cAMP levels that could possibly activate Vmn2r3 through enhanced GPCR signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, which could possibly activate Vmn2r3 by modulating GPCR signaling through phosphorylation processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific phosphodiesterase inhibitor that raises cAMP levels, which could possibly activate Vmn2r3 by affecting GPCR signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inactivates Gi/o type G proteins, which could possibly activate Vmn2r3 by disrupting inhibitory GPCR signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium, which could possibly activate Vmn2r3 by influencing calcium-mediated signaling processes. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent kinase II, which could possibly activate Vmn2r3 by affecting phosphorylation events in GPCR signaling. | ||||||